Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 18.01.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
18.01.Optinose, Inc.: Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practice37XHANCE significantly reduced both symptoms and sinus opacification in participants with chronic sinusitis (chronic rhinosinusitis) in two randomized controlled Phase 3 Clinical Trials (ReOpen1 and...
► Artikel lesen
18.01.OrderYOYO A/S: OrderYOYO publishes ARR, Net Revenue and EBITDA significantly above latest guidance. 2024 guidance significantly raised41Company Announcement No. 69 - 2024 OrderYOYO A/S Inside InformationCopenhagen, January 18, 2024 Highlights Business continues to perform strongly and above guidance. Highly focused strategy...
► Artikel lesen
18.01.Etteplan Oyj: Etteplan issues a profit warning: according to the preliminary result, Etteplan's revenue for 2023 is about EUR 359 million and the operating profit (EBIT) is about EUR 25.4 million43Etteplan Oyj, Stock Exchange Release/Insider information, January 18, 2024 at 8 a.m. EET Etteplan issues a profit warning According to the preliminary result, Etteplan's revenue for 2023 is about...
► Artikel lesen
18.01.Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination181WEST HOLLYWOOD, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. ("Bannix") announced today that its board of directors (the "Board") has decided to extend the date by which Bannix...
► Artikel lesen
18.01.Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap187REPOSE® met its primary endpoint of non-inferiority between the pain visual analog scale outcomes for neurectomy with Axoguard Nerve Cap® vs. standard-of-care neurectomy at Month 12. Axoguard Nerve...
► Artikel lesen
18.01.GH Research PLC: GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression150DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
► Artikel lesen
18.01.Aimei Health Technology Co., Ltd. Announces the Separate Trading of its Ordinary Shares and Rights Commencing January 22, 2024116NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd. ("Aimei") announced today that, commencing January 22, 2024, holders of the units sold in the Company's initial public...
► Artikel lesen
18.01.Arisz Acquisition Corp. Announces Extension of Deadline to Complete Business Combination69New York, NY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Arisz Acquisition Corp. (NASDAQ: ARIZ ("Arisz" or the "Company"), a special purpose acquisition company, announced today that Arisz Investments LLC...
► Artikel lesen
18.01.Mesa Air Group, Inc.: Mesa Air Group Enters New Agreements with United Airlines for Improved Operating and Financing Terms and Provides Update on CRJ-900 Asset Sale Program284PHOENIX, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) ("Mesa" or the "Company") today announced agreements with United Airlines ("United") to amend its capacity purchase agreement...
► Artikel lesen
18.01.OceanFirst Financial Corp. Announces Quarterly and Annual Earnings and Financial Results1.928RED BANK, N.J., Jan. 18, 2024 (GLOBE NEWSWIRE) -- OceanFirst Financial Corp. (NASDAQ:"OCFC") (the "Company"), the holding company for OceanFirst Bank N.A. (the "Bank"), announced net income available...
► Artikel lesen
18.01.Bioventus, Inc.: Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility259DURHAM, N.C., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, today announced that it has entered...
► Artikel lesen
18.01.Bird Construction Inc: Bird Bolsters Capabilities, Capacity, and Recurring Revenue With Agreement to Acquire Leading Alberta Electrical Service Provider210MISSISSAUGA, Ontario, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bird Construction Inc. (TSX: BDT) announced today that it has acquired the assets of NorCan Electric Inc. ("NorCan") for a total consideration...
► Artikel lesen
18.01.GitLab Inc.: GitLab Appoints Sabrina Farmer as Chief Technology Officer457SAN FRANCISCO, Jan. 18, 2024 (GLOBE NEWSWIRE) -- All Remote - GitLab Inc., the most comprehensive AI-powered DevSecOps platform, today announced the appointment of Sabrina Farmer as its chief technology...
► Artikel lesen
18.01.SEALSQ Unveils AIoT Strategy with WISeAI.IO at Davos AI Roundtable372Davos, Switzerland, Jan. 18, 2024 (GLOBE NEWSWIRE) -- SEALSQ Corp ("SEALSQ" or "Company") (NASDAQ: LAES), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology...
► Artikel lesen
18.01.Phaxiam Therapeutics S.A.: PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024361Lyon (France) and Cambridge (MA, US), January 18, 2024, at 10:05pm CET - PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a biopharmaceutical company developing innovative treatments for severe and...
► Artikel lesen
18.01.QIAGEN N.V.: QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million322Venlo, the Netherlands, Jan. 18, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced details for completion of the synthetic share repurchase plan to return...
► Artikel lesen
18.01.NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders224BELTSVILLE, Md., Jan. 18, 2024 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines...
► Artikel lesen
18.01.Ikena Oncology, Inc.: Ikena Oncology Outlines Key Priorities and Provides Corporate Updates289IK-930 optimized formulation now in the clinic; on track to deliver additional monotherapy data in 2H 2024 IK-595 first cohort treated and cleared safety evaluation window Focused execution on core...
► Artikel lesen
18.01.Bank OZK Announces Record Fourth Quarter and Full Year 2023 Earnings379LITTLE ROCK, Ark., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bank OZK (the "Bank") (Nasdaq: OZK) today announced that net income available to common stockholders for the fourth quarter of 2023 was a record...
► Artikel lesen
18.01.PMV Pharmaceuticals, Inc.: PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway239Prioritization of PC14586 development and focused discovery research efforts results in a workforce reduction of approximately 30%Unaudited cash, cash equivalents, and marketable securities totaling...
► Artikel lesen
Seite:  Weiter >>